GRSRX
Price
$55.37
Change
+$0.59 (+1.08%)
Updated
Sep 8 closing price
Net Assets
2.06B
NRFYX
Price
$11.54
Change
+$0.02 (+0.17%)
Updated
Sep 8 closing price
Net Assets
35.65M
Interact to see
Advertisement

GRSRX vs NRFYX

Header iconGRSRX vs NRFYX Comparison
Open Charts GRSRX vs NRFYXBanner chart's image
Cohen & Steers Global Realty R
Price$55.37
Change+$0.59 (+1.08%)
VolumeN/A
Net Assets2.06B
Natixis AEW Global Focused Real Estate Y
Price$11.54
Change+$0.02 (+0.17%)
VolumeN/A
Net Assets35.65M
GRSRX vs NRFYX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GRSRX vs. NRFYX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRSRX is a StrongBuy and NRFYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GRSRX has more cash in the bank: 2.06B vs. NRFYX (35.6M). NRFYX pays higher dividends than GRSRX: NRFYX (3.04) vs GRSRX (2.24). GRSRX was incepted earlier than NRFYX: GRSRX (11 years) vs NRFYX (25 years). NRFYX (1.76) is less costly to investors than GRSRX (1.34). NRFYX is a more actively managed with annual turnover of: 81.00 vs. GRSRX (67.00). GRSRX has a lower initial minimum investment than NRFYX: GRSRX (0) vs NRFYX (100000). NRFYX annual gain was more profitable for investors over the last year : 0.95 vs. GRSRX (0.88). GRSRX return over 5 years is better than : 25.20 vs. NRFYX (22.24).
GRSRXNRFYXGRSRX / NRFYX
Total Expense Ratio1.340.90149%
Annual Report Gross Expense Ratio1.341.7676%
Fund Existence11 years25 years-
Gain YTD9.5448.052119%
Front LoadN/AN/A-
Min. Initial Investment0100000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.06B35.6M5,784%
Annual Yield % from dividends2.243.0474%
Returns for 1 year0.880.9593%
Returns for 3 years13.6217.8176%
Returns for 5 years25.2022.24113%
Returns for 10 years53.23-1.67-3,184%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALPMY11.480.18
+1.59%
Astellas Pharma, Inc.
VGMIF0.06N/A
N/A
Visible Gold Mines, Inc.
XVIPF20.54N/A
N/A
Xvivo Perfusion AB
FGFI19.10N/A
N/A
First Greenwich Financial Inc.
KWPCF25.50N/A
N/A
Kewpie Corp